Home Current Issue Previous Issues Collections CE Podcasts For Authors Journal Info
Skip Navigation LinksHome > September/October 2013 - Volume 5 - Issue 5 > Bimatoprost in the Treatment of Hypotrichosis
Journal of the Dermatology Nurses' Association:
doi: 10.1097/JDN.0b013e3182a52462
Feature Articles

Bimatoprost in the Treatment of Hypotrichosis

Bratton, Emily M.; Davies, Brett W.; Hink, Eric M.; Durairaj, Vikram D.

Collapse Box

Abstract

Hypotrichosis plays a role in the perception of beauty and attractiveness for many patients. Bimatoprost ophthalmic solution (0.03%; Latisse, Allergan, Inc., Irvine, CA) aids in the treatment of hypotrichosis and offers a safe and effective method of achieving fuller, darker, and longer eyelashes, creating an aesthetically pleasing outcome. Nursing staff must obtain a comprehensive basis of knowledge with regard to the pharmacology, accurate application, and side effects of the drug in order to counsel patients on appropriate use and expected outcome.

Copyright © 2013 Dermatology Nurses’ Association

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.